Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer’s disease: Involvement of PI3-kinase, eNOS and NFκB-Reference-Cited by-同舟云学术

Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer’s disease: Involvement of PI3-kinase, eNOS and NFκB

Published:2018-10 Issue: Volume:351 Page:4-16
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Kumar Manish^ORCID,Bansal Nitin

Funder

AICTE, New Delhi

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference79 articles.

1. Update on Alzheimer’s disease therapy and prevention strategies;Graham;Annu. Rev. Med.,2017

2. Is Alzheimer’s disease a type 3 diabetes? A critical appraisal;Kandimalla;Biochim. Biophys. Acta,2017

3. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer’s disease and ROCK1 depletion reduces amyloid-β levels in brain;Henderson;J. Neurochem.,2016

4. Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders;Hensel;Front. Neurosci.,2015

5. ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration;Tonges;Front. Mol. Neurosci.,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fasudil alleviates alcohol-induced cognitive deficits and hippocampal morphology injury partly by altering the assembly of the actin cytoskeleton and microtubules;Behavioural Brain Research;2024-08

2. Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for down syndrome;Neurochemistry International;2024-03

3. Hippocampal acetylcholinesterase activation induced by streptozotocin in mice is protected by an organotellurium compound without evidence of toxicity;Anais da Academia Brasileira de Ciências;2024

4. Current Trends in the Animal Models for Screening of Nootropic Agents: A Systematic Review;Current Reviews in Clinical and Experimental Pharmacology;2023-11

5. Protein Kinases and their Inhibitors Implications in Modulating Disease Progression;The Protein Journal;2023-09-28